Dr Dominic Burg

Biography

 Dr Dominic Burg is an experienced scientist and project manager with a diverse and extensive skillset developed over more than 10 years in multidisciplinary research.  Dominic has overarching responsibility for technical and scientific matters relating to both business development and product development for Cellmid. He is also responsible for managing the various pre-clinical and collaborative programmes for Lyramid and Kinera.  Additionally, Dominic is involved in managing the R&D behind Advangen, working closely with the Japanese R&D team.    Dominic undertook his PhD studies at the University of NSW School of Biotechnology and Biomolecular Sciences.    Following his PhD studies, Dominic underwent post doctoral training at the University of Sydney, studying the systems biology of complex inflammatory processes underpinning cancer cachexia syndrome, and also contributed to multi-center biomarker discovery programme for colorectal cancer.   Dominic was subsequently recruited to work as a post doctoral fellow in the large multinational public-private research consortium UBIOPRED as the proteomics workstream leader, for which was based in the UK for a number of years. UBIOPRED utilised cutting-edge technologies and analytical approaches to help stratify severe asthma and improve patient outcomes.  It was during this time that Dominic honed his analytical capabilities, project management skills and strategic thinking, as well as developing a passion for fostering multidisciplinary collaboration.

Research Interest

 ..